Furthermore, Humana continues to face pressure from rising medical costs, and its benefits expense ratio increased by 270 bps y-o-y to 89%, weighing on its stock performance. Our detailed analysis ...

Humana faces significant earnings headwinds due to CMS reforms, star rating downgrades, and potential Medicaid clawbacks.

Humana Inc.’s stock was up 2% Friday after three straight sessions of declines, but investors paying attention to the performance of its bonds on Thursday may have had something of a heads-up on ...

Humana (NYSE:HUM ... by a significant 13% over the last month. Given that stock prices are usually aligned with a company's financial performance in the long-term, we decided to study its ...

The company's recent financial performance has been mixed. While Humana has maintained a solid ... HUM appears on our undervalued or overvalued stock lists. These tools provide a clearer picture ...

Shares of Humana (HUM) are plummeting after the company ... and discuss how the rating is weighing on the health insurer's stock performance. For more expert insight and the latest market action ...

This was the stock's second consecutive day of losses.

Humana (NYSE: HUM) currently trades around ... It compares these trends to the stock’s performance during the 2008 recession. In contrast, here’s how HUM stock and the broader market performed ...

Sarah James, a stock analyst with Cantor Fitzgerald ... The lower rating won’t affect Humana’s performance until 2026, but the company said it was “disappointed with its performance and ...

The company said it is disappointed in its performance ... “Humana Plunges as Medicare Quality Rating Drop Threatens Revenue.” Watch These UnitedHealth Price Levels as Stock Extends Slide ...